SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.49 |
| Enterprise Value ($M) | 0.12 |
| Book Value ($M) | 0.61 |
| Book Value / Share | 0.46 |
| Price / Book | 5.76 |
| NCAV ($M) | -0.75 |
| NCAV / Share | -0.57 |
| Price / NCAV | -4.63 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -35.02 |
| Return on Assets (ROA) | -1.02 |
| Return on Equity (ROE) | -2.22 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.91 |
| Current Ratio | 0.91 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.44 |
| Assets | 8.80 |
| Liabilities | 8.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.42 |
| Operating Income | -25.45 |
| Net Income | -22.55 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -16.11 |
| Cash from Investing | -0.01 |
| Cash from Financing | 0.85 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Dellora Investments LP | 0.00 | -100.00 | |
| 13G/A | Schonfeld Strategic Advisors LLC | 0.18 | -99.75 | |
| 13G/A | Altium Capital Management LP | 4.99 | -53.70 | |
| 13G/A | Acorn Bioventures, L.p. | 0.00 | -100.00 | |
| 13G | Lind Global Fund II LP | 9.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 467,390 | 1,522,280 | 30.70 | |
| 5,252,163 | 2,271,784 | 231.19 | |
| 4,554,885 | 2,715,734 | 167.72 | |
| 42,293 | 178,049 | 23.75 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CTXR – Citius Pharmaceuticals, Inc. | CUE – Cue Biopharma, Inc. |
| CVKD – Cadrenal Therapeutics, Inc. | CYCN – Cyclerion Therapeutics, Inc. |
| CYRX – Cryoport, Inc. |